Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 12,385.80%2.37M | 10,666.52%1.08M | 722.55%204.59K | 300.28%420.5K | 1,051.61%366.66K | 155.70%18.95K | -81.63%10.02K | -69.53%24.87K | 6.32%105.05K | 17.41%-38.53K |
| Selling and administrative expenses | 8,486.46%1.11M | 10,012.75%390.15K | 350.38%87.91K | 323.26%343.63K | 871.45%307.38K | 125.45%12.87K | -89.46%3.86K | -76.08%19.52K | -17.83%81.19K | -14.44%-39.84K |
| -Selling and marketing expense | --371.06K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -General and administrative expense | 5,603.51%734.1K | 10,012.75%390.15K | 350.38%87.91K | 323.26%343.63K | 871.45%307.38K | 125.45%12.87K | -89.46%3.86K | -76.08%19.52K | -17.83%81.19K | -14.44%-39.84K |
| Depreciation amortization depletion | --3.83K | --1.05K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Depreciation and amortization | --3.83K | --1.05K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other operating expenses | 20,585.58%1.26M | 11,058.71%687.71K | 2,079.95%116.67K | 222.09%76.88K | 4,415.38%59.29K | 257.29%6.07K | -65.66%6.16K | --5.35K | --23.87K | --1.31K |
| Operating profit | -12,385.80%-2.37M | -10,666.52%-1.08M | -722.55%-204.59K | -300.28%-420.5K | -1,051.61%-366.66K | -155.70%-18.95K | 81.63%-10.02K | 69.53%-24.87K | -6.32%-105.05K | -17.41%38.53K |
| Net non-operating interest income (expenses) | 24.92K | 0 | ||||||||
| Non-operating interest income | --24.92K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -477.40%-2.35K | -13.58K | -1.63K | -101.78%-611 | -100.59%-204 | -407 | -98.57%34.4K | -98.56%34.4K | ||
| Gain on sale of security | -477.40%-2.35K | ---13.58K | ---1.63K | -103.23%-611 | -101.08%-204 | ---407 | ---- | ---- | 171.20%18.9K | 194.93%18.9K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.36%15.5K | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.37%-15.5K | ---- |
| Income before tax | -12,006.56%-2.34M | -10,802.04%-1.09M | -729.12%-206.22K | -496.04%-421.11K | -603.01%-366.87K | -161.20%-19.35K | 81.63%-10.02K | 69.53%-24.87K | -103.07%-70.65K | -97.01%72.94K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -12,006.56%-2.34M | -10,802.04%-1.09M | -729.12%-206.22K | -496.04%-421.11K | -603.01%-366.87K | -161.20%-19.35K | 81.63%-10.02K | 69.53%-24.87K | -103.07%-70.65K | -97.01%72.94K |
| Net income continuous operations | -12,006.56%-2.34M | -10,802.04%-1.09M | -729.12%-206.22K | -496.04%-421.11K | -603.01%-366.87K | -161.20%-19.35K | 81.63%-10.02K | 69.53%-24.87K | -103.07%-70.65K | -97.01%72.94K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -12,006.56%-2.34M | -10,802.04%-1.09M | -729.12%-206.22K | -496.04%-421.11K | -603.01%-366.87K | -161.20%-19.35K | 81.63%-10.02K | 69.53%-24.87K | -103.07%-70.65K | -97.01%72.94K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -12,006.56%-2.34M | -10,802.04%-1.09M | -729.12%-206.22K | -496.04%-421.11K | -603.01%-366.87K | -161.20%-19.35K | 81.63%-10.02K | 69.53%-24.87K | -103.07%-70.65K | -97.01%72.94K |
| Diluted earnings per share | -0.075 | -0.02 | 0 | -0.025 | -200.00%-0.025 | 0 | 0 | 0 | 0 | -96.00%0.025 |
| Basic earnings per share | -0.075 | -0.02 | 0 | -0.025 | -200.00%-0.025 | 0 | 0 | 0 | 0 | -96.00%0.025 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.